Peter Attia· MD
it wasn't so much as a pivot but a decision to go one way rather than the other because in the beginning we thought you could do either and the decision was driven by a simple idea which is that were you to make molecules that would simply suppress the secretions of the cells but not remove the source of all of these factors you'd have a drug yet to take all the time